Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

sovereign medical ltd - tranexamic acid - oral tablet - 500mg

Malta - inglés - Medicines Authority

accord healthcare limited - tranexamic acid - solution for injection - tranexamic acid 100 mg/ml - antihemorrhagics

Malta - inglés - Medicines Authority

accord healthcare limited - tranexamic acid - solution for injection - tranexamic acid 100 mg/ml - antihemorrhagics

Malta - inglés - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - tranexamic acid - solution for injection - tranexamic acid 100 mg/ml - antihemorrhagics

Malta - inglés - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - tranexamic acid - solution for injection - tranexamic acid 100 mg/ml - antihemorrhagics

Australia - inglés - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - tranexamic acid, quantity: 100 mg/ml - injection - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - adults for the reduction of peri? and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty. paediatrics for the reduction of peri? and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - tranexamic acid, quantity: 100 mg/ml - injection - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - adults for the reduction of peri? and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty. paediatrics for the reduction of peri? and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery.

Canadá - inglés - Health Canada

genmed a division of pfizer canada ulc - tranexamic acid - tablet - 500mg - tranexamic acid 500mg - hemostatics

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - tranexamic acid - solution for injection - 100 milligram(s)/millilitre - amino acids; tranexamic acid

Estados Unidos - inglés - NLM (National Library of Medicine)

exela pharma sciences, llc - tranexamic acid (unii: 6t84r30kc1) (tranexamic acid - unii:6t84r30kc1) - tranexamic acid in sodium chloride injection is indicated in patients with hemophilia for short-term use (two to eight days) to reduce the risk of hemorrhage during and following tooth extraction. tranexamic acid in sodium chloride injection is contraindicated: risk summary available data from published studies, case series and case reports with tranexamic acid use in pregnant women in the second and third trimester and at the time of delivery have not identified a drug-associated risk of miscarriage or adverse maternal or fetal outcomes. there are no reports regarding the use of tranexamic acid during the first trimester of pregnancy; therefore, there are no data regarding the risk of major birth defects with use of tranexamic acid during pregnancy. however, tranexamic acid is known to pass the placenta and appears in cord blood at concentrations approximately equal to maternal concentration (see data). reproduction studies performed in mice, rats, and rabbits have not revealed any adverse effects on the fet